Healthcare

Endocrine Testing Market Size to Worth USD 12.8 Billion By 2032

The global endocrine testing market size is expected to be worth around USD 12.8 billion by 2032 from USD 5.45 billion in 2022, growing at a CAGR of 8.92% during the forecast period from 2022 to 2032.

Endocrine Testing Market Size 2023 To 2032


Key Takeaways:

  • North America has accounted revenue share of around 46% in 2022.
  • By End-user, the commercial laboratories segment captured more than 49% of revenue share in 2022.
  • The hospital end-user segment has captured a revenue share of 35% in 2022.
  • By Test Type, the human Chorionic Gonadotropin (hCG) hormone test segment dominated the market in 2022, the segment is expected to continue the trend during the forecast period.
  • By Technology, the immunoassay segment dominated the market in 2022.

Report Summary

The latest released research study on Global Printed and Endocrine testing Market, offers a detailed overview of the factors influencing the global business scope. The Printed and Endocrine testing Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Printed and Endocrine testing Market. The study also provides information on past and current market trends and developments, factors, capacities, technologies, and changes in market capital structure Printed and Endocrine testing Market. The study will assist market participants and market consultants to understand the continuing structure of the Printed and Endocrine testing Market. Our analysts monitoring the situation across the globe explain that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3211

The report endeavors to offer a 360-degree analysis of the global Printed and Endocrine testing Market on the back of an insightful study of the prevailing demand and supply trends, important fiscal statistics of major players sustaining in the market, and the influence of latest economic advancements on the market. Developments in each geographical region is charted using authentic historical data with a view to help gauge the future trajectory of the market across the globe. SWOT analysis is conducted to identify the strengths, weaknesses, opportunities, and threats that these companies forecast to witness during the forecast period.

Report Scope of the Endocrine Testing Market:

Report Coverage Details
Market Size in 2023 USD 5.93 Billion
Market Size by 2032 USD 12.8 Billion
Growth Rate from 2023 to 2032 CAGR of 8.92%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Test Type, By Technology, and By End-User
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: Point-of-Care Medical Imaging Market Size to Worth USD 5.9 Billion By 2032

Market Size Estimation

Based on the provided information, it seems that the data you have is sourced from Precedence Research Reports. They have used both top-down and bottom-up approaches to estimate and validate the global market size for various parameters such as company, regional division, product type, and application (end users).

The endocrine testing market size estimations in the report are based on the selling price, excluding any discounts offered by manufacturers, distributors, wholesalers, or traders. The market share analysis for each segment and region is determined using the product utilization rate and average selling price.

To determine the revenues, percentage splits, market shares, growth rates, and breakdowns of the product markets for major manufacturers, the report relies on secondary sources and verifies the information through primary sources.

Major companies operating in this area

  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • AB Sciex
  • Agilent Technologies Inc.
  • Ortho Clinical Diagnostics
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated

Endocrine Testing Market Segmentation

By Test Type

  • Estradiol (E2) Test
  • Dehydroepiandrosterone Sulfate (DHEAS) Test
  • Progesterone Test
  • Testosterone Test
  • Thyroid Stimulating Hormone (TSH) Test
  • Prolactin Test
  • Follicle Stimulating Hormone (FSH) Test
  • Human Chorionic Gonadotropin (hCG) Hormone Test
  • Luteinizing Hormone (LH) Test
  • Cortisol Test
  • Insulin Test
  • Others

By Technology

  • Immunoassay
  • Chromatography
  • Mass Spectroscopy
  • Nucleic Acid Based

By End-User

  • Hospitals
  • Commercial Laboratories
  • Ambulatory Care Centers
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies.
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions, and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops the Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Endocrine Testing Market 

5.1. COVID-19 Landscape: Endocrine Testing Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Endocrine Testing Market, By Test Type

8.1. Endocrine Testing Market, by Test Type, 2023-2032

8.1.1 Estradiol (E2) Test

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Dehydroepiandrosterone Sulfate (DHEAS) Test

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Progesterone Test

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Testosterone Test

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Thyroid Stimulating Hormone (TSH) Test

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Prolactin Test

8.1.6.1. Market Revenue and Forecast (2020-2032)

8.1.7. Follicle Stimulating Hormone (FSH) Test

8.1.7.1. Market Revenue and Forecast (2020-2032)

8.1.8. Human Chorionic Gonadotropin (hCG) Hormone Test

8.1.8.1. Market Revenue and Forecast (2020-2032)

8.1.9. Luteinizing Hormone (LH) Test

8.1.9.1. Market Revenue and Forecast (2020-2032)

8.1.10. Cortisol Test

8.1.10.1. Market Revenue and Forecast (2020-2032)

8.1.11. Insulin Test

8.1.11.1. Market Revenue and Forecast (2020-2032)

8.1.12. Others

8.1.12.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Endocrine Testing Market, By Technology

9.1. Endocrine Testing Market, by Technology, 2023-2032

9.1.1. Immunoassay

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Chromatography

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Mass Spectroscopy

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Nucleic Acid Based

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Endocrine Testing Market, By End-User 

10.1. Endocrine Testing Market, by End-User, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Commercial Laboratories

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Ambulatory Care Centers

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Endocrine Testing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.1.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.3. Market Revenue and Forecast, by End-User (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Test Type (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End-User (2020-2032)

Chapter 12. Company Profiles

12.1. Abbott Laboratories

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. bioMerieux SA

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Bio-Rad Laboratories Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. DiaSorin S.p.A.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. F. Hoffmann-La Roche Ltd.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. AB Sciex

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Agilent Technologies Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Ortho Clinical Diagnostics

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Laboratory Corporation of America Holdings

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Quest Diagnostics Incorporated

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Show More

Related Articles

Back to top button